Close Menu

NEW YORK – ERS Genomics said on Wednesday that it has granted Japanese drug maker Otsuka Pharmaceutical a license to its CRISPR-Cas9 patent portfolio, which Otsuka said it will use for its internal research and development programs to address areas of unmet medical need.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.